8-K
COGNEX CORP (CGNX)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): May 6, 2021
| Cognex Corporation | ||
|---|---|---|
| (Exact name of registrant as specified in charter) | ||
| Massachusetts | 001-34218 | 04-2713778 |
| --- | --- | --- |
| (State or other jurisdiction<br><br> <br>of incorporation) | (Commission<br><br> <br>File Number) | (IRS Employer<br><br> <br>Identification No.) |
| One Vision Drive, Natick, Massachusetts | 01760-2059 | |
| --- | --- | |
| (Address of principal executive offices) | (Zip Code) |
Registrant's telephone number, including area code: (508) 650-3000
| N/A |
|---|
| (Former name or former address, if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions \(see General Instruction A.2. below\):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| --- | --- |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| --- | --- |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| --- | --- |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
|---|---|---|
| Common Stock, par value $.002 per share | CGNX | The NASDAQ Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
| Emerging growth company ☐ |
|---|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 2.02 | Results of Operations and Financial Condition |
|---|
On May 6, 2021, Cognex Corporation (the “Company”) issued a news release to report its financial results for the quarter ended April 4, 2021. The release is furnished as Exhibit 99.1 hereto. The information in Item 2.02 of this Current Report on Form 8-K, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, regardless of any general incorporation language in such filing.
| Item 8.01 | Other Events |
|---|
On May 6, 2021, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.06 per share. The dividend is payable on June 4, 2021 to all shareholders of record at the close of business on May 21, 2021.
| Item 9.01 | Financial Statements and Exhibits |
|---|
(d) Exhibits
| Exhibit No. | Description |
|---|---|
| 99.1 | News release, dated May 6, 2021, by Cognex Corporation (furnished herewith) |
| 104 | Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| COGNEX CORPORATION | |
|---|---|
| Dated: May 6, 2021 | By:/s/ Paul Todgham |
| Paul Todgham | |
| Senior Vice President and Chief Financial Officer |
Exhibit 99.1
Cognex Reports Record First Quarter Results
NATICK, Mass.--(BUSINESS WIRE)--May 6, 2021--Cognex Corporation (NASDAQ:CGNX) today reported financial results for the first quarter of 2021. The company announced new records for first quarter revenue, net income, and net income per diluted share. Table 1 below shows selected financial data for Q1-21 compared with Q1-20 and Q4-20.
| Table 1 | ||||
|---|---|---|---|---|
| (Dollars in thousands, except per share amounts) | ||||
| Revenue | Net Income | Net Income per Diluted Share | Non-GAAP Net Income per Diluted Share* | |
| Quarterly Comparisons | ||||
| Current quarter: Q1-21 | $239,027 | $69,848 | $0.39 | $0.36 |
| Prior year’s quarter: Q1-20 | $167,235 | $20,477 | $0.12 | $0.11 |
| Change: Q1-20 to Q1-21 | 43% | 241% | 225% | 227% |
| Prior quarter: Q4-20 | $223,615 | $69,345 | $0.39 | $0.32 |
| Change: Q4-20 to Q1-21 | 7% | 1% | 0% | 13% |
*Non-GAAP net income per diluted share excludes restructuring and other charges and tax adjustments. A reconciliation from GAAP to Non-GAAP is shown in Exhibit 2 of this news release.
“Cognex started 2021 on a strong note,” said Robert J. Willett, Chief Executive Officer of Cognex. “We reported the highest first quarter revenue, net income, and earnings per share in our company’s 40-year history. We were highly profitable—reporting an operating margin of 33% in Q1-21 compared to 13% a year ago—demonstrating the leverage we have in our high-growth, high gross margin business model.”
Mr. Willett continued, “We are pleased with our achievements in the first quarter. Our strong momentum continued in the e-commerce sector of logistics. Business activity has been recovering in other end markets that have struggled over the past year. Most importantly, we introduced several innovative products in the areas of 3D vision, edge intelligence, and handheld barcode reading that we believe will contribute to revenue growth in years to come.”
Details of the Quarter
Statement of Operations Highlights – First Quarter of 2021
- Cognex reported record first quarter revenue of $239 million, which represents an increase of 43% from Q1-20 and 7% from Q4-20. A notable contribution to growth, both year-on-year and sequentially, came from continued strong performance in the e-commerce sector of logistics. Outside of logistics, revenue from each geographic region (the Americas, Asia, and Europe) increased over Q1-20 due to improved business activity in a variety of industries.
- Gross margin was 77% for Q1-21, 75% for Q1-20, and 75% for Q4-20, and within the company’s target range for all periods. The increase in gross margin, both year-on-year and sequentially, is due to higher volume and a favorable revenue mix.
- Research, Development, & Engineering (RD&E) expenses decreased by 5% from Q1-20 and 1% from Q4-20. The decrease year-on-year reflects cost-saving actions implemented by Cognex in 2020 following the COVID-19 outbreak and lower stock-based compensation expense. The savings were partially offset by the impact of foreign currency exchange rate changes.
- Selling, General & Administrative (SG&A) expenses increased by 5% from Q1-20 and decreased by 2% from Q4-20. The increase in SG&A spending year-on-year was due to higher incentive compensation related to the revenue growth as well as the impact of foreign currency exchange rate changes. The increase was partially offset by lower travel and entertainment costs and other savings. On a sequential basis, higher spending on marketing communications was offset by lower sales commissions, which were reset at the beginning of the year with relevant performance goals for 2021.
- The effective tax rate in Q1-21 was an expense of 11% compared with an expense of 11% in Q1-20 and a benefit of 7% in Q4-20. Excluding the discrete tax adjustments summarized in Exhibit 2, the effective tax rate was an expense of 18% in Q1-21, 17% in Q1-20, and 14% in Q4-20.
Balance Sheet Highlights – April 4, 2021
- Cognex’s financial position as of April 4, 2021 **** continued to be strong, with $876 million in cash and investments and no debt. In Q1-21, Cognex generated $99 million in cash from operations and $35 million in net proceeds from the exercise of stock options. In addition, during Q1-21, the company paid $11 million in dividends to shareholders and spent $6 million to repurchase its common stock. Cognex intends to continue to repurchase shares of its common stock pursuant to its existing stock repurchase program, subject to market conditions and other relevant factors.
Financial Outlook – Q2 2021
- Cognex believes revenue in Q2-21 will be between $250 million and $270 million. This range represents anticipated substantial growth over Q2-20, which was marked by significant economic disruption following the COVID-19 outbreak.
- Gross margin for Q2-21 is expected to be in the mid-70% range, and lower than the gross margin reported in recent quarters.
- Operating expenses are expected to be flat to slightly up from Q1-21.
- The effective tax rate is expected to be 18%, excluding discrete tax items.
Non-GAAP Financial Measures
- Exhibit 2 of this news release includes a reconciliation of certain financial measures from GAAP to non-GAAP. Cognex believes these non-GAAP financial measures are helpful because they allow investors to more accurately compare Cognex results over multiple periods using the same methodology that management employs in its budgeting process and in its review of Cognex’s operating results. Non-GAAP presentations exclude certain one-time discrete events, such as tax adjustments (because these costs are outside of Cognex’s normal business operations and not used by management to assess Cognex’s operating results). Additionally, the company excludes restructuring charges, intangible asset impairment charges, and excess and obsolete inventory charges because these charges result from discrete activities, such as specific restructuring actions or acquisitions, and are frequently excluded by management in evaluating Cognex’s operating results. Cognex does not intend for non-GAAP financial measures to be considered in isolation, or as a substitute for financial information provided in accordance with GAAP.
- The tax effect of items identified in the reconciliation is estimated by applying the effective tax rate to the pre-tax amount. However, if a specific tax rate or tax treatment is required because of the nature of the item and/or the tax jurisdiction where the item was recorded, the tax effect is estimated by applying the relevant specific tax rate or tax treatment, rather than the effective tax rate.
Analyst Conference Call and Simultaneous Webcast
- Cognex will host a conference call today at 5:00 p.m. Eastern Daylight Time (EDT). The telephone number is (877) 704-4573 (or (201) 389-0911 if outside the United States). A replay will begin at 8:00 p.m. EDT today and will be available until 11:59 p.m. EDT on Sunday, May 9, 2021. The telephone number for the replay is (877) 660-6853 (or (201) 612-7415 if outside the United States). The access code for both the live call and the replay is 13717939.
- A real-time audio broadcast of the conference call or an archived recording will be accessible on the Events & Presentations page of the Cognex Investor website: https://www.cognex.com/Investor.
About Cognex Corporation
Cognex Corporation designs, develops, manufactures, and markets a wide range of image-based products, all of which use artificial intelligence (AI) techniques that give them the human-like ability to make decisions on what they see. Cognex products include machine vision systems, machine vision sensors, and barcode readers that are used in factories and distribution centers around the world where they eliminate production and shipping errors.
Cognex is the world's leader in the machine vision industry, having shipped more than 3 million image-based products, representing over $8 billion in cumulative revenue, since the company's founding in 1981. Headquartered in Natick, Massachusetts, USA, Cognex has offices and distributors located throughout the Americas, Europe, and Asia. For details, visit Cognex online at www.cognex.com.
Certain statements made in this news release, which do not relate solely to historical matters, are forward-looking statements. These statements can be identified by use of the words “expects,” “anticipates,” “estimates,” “believes,” “projects,” “intends,” “plans,” “will,” “may,” “shall,” “could,” “should,” and similar words and other statements of a similar sense. These statements are based on our current estimates and expectations as to prospective events and circumstances, which may or may not be in our control and as to which there can be no firm assurances given. These forward-looking statements, which include statements regarding business and market trends, future financial performance, the expected impact of the COVID-19 pandemic on our assets, business and results of operations, customer order rates and timing of related revenue, future product mix, restructuring and other cost-savings initiatives, research and development activities, new product offerings, capital expenditures, investments, acquisitions, liquidity, dividends and stock repurchases, strategic plans, and estimated tax benefits and expenses and other tax matters, involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include: (1) the impact, duration, and severity of the COVID-19 pandemic; (2) potential disruptions to our business due to restructuring activities; (3) the loss of, or curtailment of purchases by, large customers in the consumer electronics and logistics industries; (4) the reliance on revenue from the automotive industry; (5) the reliance on key suppliers to manufacture and deliver critical components for our products and potential disruptions in the supply chain; (6) the failure to effectively manage product transitions or accurately forecast customer demand; (7) the inability to design and manufacture high-quality products; (8) the inability to attract and retain skilled employees and maintain our unique corporate culture; (9) the failure to effectively manage our growth; (10) the inability to achieve growth in revenue and profits from the logistics industry; (11) the technological obsolescence of current products and the inability to develop new products; (12) the failure to properly manage the distribution of products and services; (13) the impact of competitive pressures; (14) the challenges in integrating and achieving expected results from acquired businesses; (15) potential disruptions in our business systems; (16) information security breaches; (17) the inability to protect our proprietary technology and intellectual property; (18) potential impairment charges with respect to our investments or acquired intangible assets; (19) exposure to additional tax liabilities; (20) fluctuations in foreign currency exchange rates and the use of derivative instruments; (21) our involvement in time-consuming and costly litigation; (22) unfavorable global economic conditions; (23) economic, political, and other risks associated with international sales and operations; and the other risks detailed in Cognex reports filed with the SEC, including its Form 10-K for the fiscal year ended December 31, 2020 and Form 10-Q for the fiscal quarter ended April 4, 2021. You should not place undue reliance upon any such forward-looking statements, which speak only as of the date made. Cognex disclaims any obligation to update forward-looking statements after the date of such statements.
| Exhibit 1 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| COGNEX CORPORATION | |||||||||
| Statements of Operations | |||||||||
| (Unaudited) | |||||||||
| Dollars in thousands, except per share amounts | |||||||||
| Three-months Ended | |||||||||
| April 4, 2021 | December 31, <br><br> 2020 | March 29, <br><br> 2020 | |||||||
| Revenue | $ | 239,027 | $ | 223,615 | $ | 167,235 | |||
| Cost of revenue (1) | 54,045 | 55,160 | 41,200 | ||||||
| Gross margin | 184,982 | 168,455 | 126,035 | ||||||
| Percentage of revenue | 77 | % | 75 | % | 75 | % | |||
| Research, development, and engineering expenses (1) | 34,105 | 34,399 | 35,946 | ||||||
| Percentage of revenue | 14 | % | 15 | % | 21 | % | |||
| Selling, general, and administrative expenses (1) | 72,424 | 74,096 | 69,138 | ||||||
| Percentage of revenue | 30 | % | 33 | % | 41 | % | |||
| Restructuring charges | — | 875 | — | ||||||
| Operating income | 78,453 | 59,085 | 20,951 | ||||||
| Percentage of revenue | 33 | % | 26 | % | 13 | % | |||
| Foreign currency gain (loss) | (1,008 | ) | 4,007 | (3,003 | ) | ||||
| Investment and other income | 1,386 | 1,828 | 5,046 | ||||||
| Income before income tax expense (benefit) | 78,831 | 64,920 | 22,994 | ||||||
| Income tax expense (benefit) | 8,983 | (4,425 | ) | 2,517 | |||||
| Net income | $ | 69,848 | $ | 69,345 | $ | 20,477 | |||
| Percentage of revenue | 29 | % | 31 | % | 12 | % | |||
| Net income per weighted-average common and common-equivalent share: | |||||||||
| Basic | $ | 0.40 | $ | 0.40 | $ | 0.12 | |||
| Diluted | $ | 0.39 | $ | 0.39 | $ | 0.12 | |||
| Weighted-average common and common-equivalent shares outstanding: | |||||||||
| Basic | 176,288 | 175,220 | 172,408 | ||||||
| Diluted | 179,971 | 178,590 | 175,602 | ||||||
| Cash dividends per common share | $ | 0.060 | $ | 2.060 | $ | 0.055 | |||
| Cash and investments per common share | $ | 4.96 | $ | 4.37 | $ | 4.92 | |||
| Book value per common share | $ | 7.68 | $ | 7.18 | $ | 7.73 | |||
| (1) Amounts include stock-based compensation expense, as follows: | |||||||||
| Cost of revenue | $ | 248 | $ | 324 | $ | 354 | |||
| Research, development, and engineering | 4,003 | 2,805 | 5,366 | ||||||
| Selling, general, and administrative | 7,758 | 7,456 | 9,070 | ||||||
| Total stock-based compensation expense | $ | 12,009 | $ | 10,585 | $ | 14,790 |
| Exhibit 2 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| COGNEX CORPORATION | |||||||||
| Reconciliation of Selected Items from GAAP to Non-GAAP | |||||||||
| (Unaudited) | |||||||||
| Dollars in thousands, except per share amounts | |||||||||
| Three-months Ended | |||||||||
| April 4, 2021 | December 31, <br><br> 2020 | March 29, <br><br> 2020 | |||||||
| Discrete tax adjustments reconciliation | |||||||||
| Income before income tax expense (benefit) (GAAP) | $ | 78,831 | $ | 64,920 | $ | 22,994 | |||
| Income tax expense (benefit) (GAAP) | $ | 8,983 | $ | (4,425 | ) | $ | 2,517 | ||
| Effective tax rate (GAAP) | 11 | % | (7 | )% | 11 | % | |||
| Discrete tax benefit related to stock-based compensation | 5,207 | 2,342 | 1,680 | ||||||
| Discrete tax benefit (expense) related to tax return filings and other | — | 11,441 | (242 | ) | |||||
| Total discrete tax adjustments | $ | 5,207 | $ | 13,783 | $ | 1,438 | |||
| Income tax expense (Non-GAAP) | $ | 14,190 | $ | 9,358 | $ | 3,955 | |||
| Effective tax rate (Non-GAAP) | 18 | % | 14 | % | 17 | % | |||
| Restructuring and other charges and discrete tax adjustments reconciliation | |||||||||
| Net income (GAAP) | $ | 69,848 | $ | 69,345 | $ | 20,477 | |||
| Excess and obsolete inventory charges | 705 | 522 | 1,065 | ||||||
| Restructuring charges | — | 875 | — | ||||||
| Tax effect on restructuring and other charges | (127 | ) | (196 | ) | (181 | ) | |||
| Discrete tax adjustments | (5,207 | ) | (13,783 | ) | (1,438 | ) | |||
| Net income (Non-GAAP) | $ | 65,219 | $ | 56,763 | $ | 19,923 | |||
| Percentage of revenue (Non-GAAP) | 27 | % | 25 | % | 12 | % | |||
| Net income per diluted weighted-average common and common-equivalent share (GAAP) | $ | 0.39 | $ | 0.39 | $ | 0.12 | |||
| Per share impact of non-GAAP adjustments identified above | (0.03 | ) | (0.07 | ) | (0.01 | ) | |||
| Net income per diluted weighted-average common and common-equivalent share (Non-GAAP) | $ | 0.36 | $ | 0.32 | $ | 0.11 | |||
| Diluted weighted-average common and common-equivalent shares outstanding | 179,971 | 178,590 | 175,602 |
| Exhibit 3 | ||||
|---|---|---|---|---|
| COGNEX CORPORATION | ||||
| Balance Sheets | ||||
| (Unaudited) | ||||
| Dollars in thousands | ||||
| April 4, 2021 | December 31, 2020 | |||
| Assets | ||||
| Cash and investments | $ | 876,284 | $ | 767,438 |
| Accounts receivable | 128,822 | 125,696 | ||
| Inventories | 61,392 | 60,830 | ||
| Property, plant, and equipment | 77,081 | 79,173 | ||
| Operating lease assets | 20,784 | 22,582 | ||
| Goodwill and intangible assets | 257,664 | 259,633 | ||
| Deferred tax assets | 429,801 | 434,704 | ||
| Other assets | 57,128 | 50,646 | ||
| Total assets | $ | 1,908,956 | $ | 1,800,702 |
| Liabilities and Shareholders' Equity | ||||
| Accounts payable and accrued expenses | $ | 81,392 | $ | 93,534 |
| Deferred revenue and customer deposits | 51,660 | 21,274 | ||
| Operating lease liabilities | 24,028 | 26,230 | ||
| Income taxes | 74,538 | 72,551 | ||
| Deferred tax liabilities | 310,884 | 314,952 | ||
| Other liabilities | 9,453 | 9,959 | ||
| Shareholders' equity | 1,357,001 | 1,262,202 | ||
| Total liabilities and shareholders' equity | $ | 1,908,956 | $ | 1,800,702 |
Contacts
Susan Conway
Investor Relations
+1 508-650-3353
Susan.conway@cognex.com